tradingkey.logo

Zimmer Biomet Holdings Inc

ZBH
View Detailed Chart
89.910USD
+1.180+1.33%
Close 02/06, 16:00ETQuotes delayed by 15 min
17.82BMarket Cap
22.18P/E TTM

Zimmer Biomet Holdings Inc

89.910
+1.180+1.33%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.33%

5 Days

+3.26%

1 Month

-5.11%

6 Months

-1.36%

Year to Date

-0.01%

1 Year

-12.45%

View Detailed Chart

Key Insights

Zimmer Biomet Holdings Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 32 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 102.34.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Zimmer Biomet Holdings Inc's Score

Industry at a Glance

Industry Ranking
32 / 205
Overall Ranking
119 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Zimmer Biomet Holdings Inc Highlights

StrengthsRisks
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 7.68B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 21.51%.
Undervalued
The company’s latest PE is 22.18, at a low 3-year percentile range.
Held by Brandes Investmen
Star Investor Brandes Investmen holds 15.49K shares of this stock.

Analyst Rating

Based on 30 analysts
Hold
Current Rating
102.338
Target Price
+15.34%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Zimmer Biomet Holdings Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Zimmer Biomet Holdings Inc Info

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
Ticker SymbolZBH
CompanyZimmer Biomet Holdings Inc
CEOTornos (Ivan)
Websitehttps://www.zimmerbiomet.com/en
KeyAI